Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
seraprevir (2 trials)
sofosbuvir (sovaldi) (2 trials)
Communicable Diseases (Phase 3)
Hepatitis (Phase 3)
Hepatitis A (Phase 3)
Hepatitis C (Phase 3)
Infections (Phase 3)
Virus Diseases (Phase 3)
Trials (2 total)
Trial APIs (2 total)